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Abstract
Background: Although pharmacological treatment has increased the average life expectancy of patients with cystic
fibrosis, the median survival of females is shorter than that of males. In vitro and in vivo studies have shown
that estrogens play a relevant role in the disease progression.
The aim of this study was to investigate the effects of 17β-estradiol and tamoxifen citrate (TMX) on calcium-activated
chloride channel (CaCC) currents in human bronchial epithelial cells carrying the ΔPhe508-CFTR mutation both in
homozygosis and in heterozygosis.
Methods: Perforated patch clamp experiments were performed on single cells of the immortalized cell lines CFBE and
IB3–1. Gramicidin (10 or 20 μM) was added to the electrode solution to reach the whole cell configuration.
The electrical stimulation protocol consisted of square voltages ranging from − 80 to + 80 mV, in steps of
20 mV and with a duration of 800 msec.
Results: The presence of 17β-estradiol significantly reduced the CaCC currents, both in basal conditions and
in the presence of ATP (100 μM). The addition of TMX (10 μM) completely restored the currents abolished by
17β-estradiol, in basal conditions and after stimulation with ATP in both CFBE and IB3–1 cells. TMX had a
strong, direct action on membrane current density, which significantly increased more than 4-fold in both
cases. The membrane current stimulation produced by TMX was further enhanced by the addition of ATP.
CFBE cells incubated for 24 h with 3 μM VX-809 (a CFTR corrector) and then acutely stimulated with VX-770
(a CFTR potentiator) in the presence of forskolin, showed an increase of chloride currents which were
abolished by Inh-172. The chloride current density induced by TMX + ATP was, on average, greater than that
obtained with VX-809 + VX-770 + forskolin. The currents elicited by TMX + ATP were abolished by the addition
of NPPB, a CaCC inhibitor. The combined administration of TMX/ATP and VXs/FSK had an additional effect on
chloride currents.
Conclusions: Our results show that TMX restores CaCC currents inhibited by 17ß-estradiol and directly activates the
transmembrane chloride currents potentiated by ATP, an effect which is mutation independent. The combined effect
of TMX with current used treatments for cystic fibrosis could be of benefit to patients.
Keywords: Chloride current, CFTR mutation, CaCC, Ion channels, Tamoxifen, 17β-estradiol
* Correspondence: michele.mazzanti@unimi.it
2Department of Biosciences, Laboratory of Cellular and Molecular Physiology,
University of Milano, via Celoria 26, I-20133 Milan, Italy
Full list of author information is available at the end of the article
© The Author(s). 2018 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Imberti et al. Respiratory Research  (2018) 19:198 
https://doi.org/10.1186/s12931-018-0901-1
Background
Cystic fibrosis (CF) is the most common fatal genetic
disease in the white population. It is caused by muta-
tions in a gene encoding the Cystic Fibrosis Transmem-
brane Conductance Regulator (CFTR), a protein that
functions mainly as a chloride channel. A mutation of
the CFTR gene usually produces abnormal proteins that
do not transport chloride ions and water properly, or are
not transported to the apical membrane [1–3]. More
than 2000 genetic CFTR variants are known, the most
frequent being the F508del. Most mutations of the CFTR
gene are missense alterations, but frameshifts, splicing,
nonsense mutations, and in-frame deletions and inser-
tions have been described. About 15% of the genetic
variants that have been identified are not associated with
the disease [3] . The CFTR channel defect is mainly in
chloride and bicarbonate transport. Interactions of
CFTR and other ion channels, particularly the epithelial
sodium channel, and interactions of CFTR with cellular
pathways related to inflammation (inflammasome) might
be important in the pathophysiology of CF [4]. The im-
portance of understanding the pathophysiology of this
disease in the first few years of life has been underscored
by recent studies showing that, by the age of 3 years, al-
most a third of children with CF have computed tomo-
graphic evidence of mucus obstruction, bronchiectasis,
and inflammation driven by neutrophils, neutrophil elas-
tase, and recurrent episodes of infection [4, 5]. The pri-
mary hypothesis to explain these clinical features is that
impaired mucociliary clearance caused by abnormal hy-
dration of airway surface liquid is the key underlying de-
fect [4, 5]. In newborn pigs with CF it has been observed
that mucus fails to detach from submucosal gland ducts
and accumulates in pulmonary airways, thus hindering
mucociliary transport, an abnormality which, at the
origin of the disease, is not dependent on infection or
inflammation [6]. With progression of the disease, ad-
vancing infection and bronchiectasis further disrupt
mucociliary transport, which, in turn, impairs bacterial
clearance and promotes resistance to antibacterial de-
fenses [4].
Although CF is not sex-linked, females with this dis-
ease experience a more rapid decline in lung function,
have more pulmonary exacerbations and have a shorter
life span compared with males with CF [7, 8]. Several
lines of evidence indicate that the female sex hormone
estrogen plays a relevant role. In vitro studies have
shown that estrogen receptors ERα and ERβ are
expressed in normal lung tissue [9, 10] and that ERα are
expressed in cell cultures from non-CF and CF patients,
at similar levels in males and females [10]. Choi and col-
leagues [11] have shown that 17β-estradiol, by interact-
ing with ERα, up-regulates MUC5B gene expression and
increases the production of MUC5B, one of the major
mucins in the human airway submucosal glands [12],
thus favoring mucus plugging. Pretreatment with the es-
trogen receptor antagonist ICI182,780 suppressed 17β-
estradiol-induced MUC5B expression [11]. Inflammation
is another important mechanism of lung injury and lung
function decline in CF patients. A recent investigation
demonstrated that exogenous administration of 17β-es-
tradiol to male CF mice increases the severity of P. aeru-
ginosa pneumonia by increasing inflammation and the
production of mucin and inflammatory cytokines [13].
Furthermore, circulating levels of estradiol correlated
with infective exacerbations among menstruating
women with CF, and the exacerbation rate per year was
significantly lower in women receiving oral contracep-
tives than in CF females with a regular or irregular men-
strual cycle [14]. Moreover, exposure of P. aeruginosa to
estradiol resulted in an increase of alginate, the predom-
inant polysaccharide produced by P. aeruginosa and im-
plicated in its pathogenicity, and enhanced the
conversion from the non-mucoid to the mucoid morph-
ology [14].
Another recent investigation showed that 17ß-estra-
diol, by reducing the ATP-induced increase in intra-
cellular Ca2+, inhibits the activity of calcium-activated
chloride channel (CaCC) [10]. Treatment with tamoxi-
fen citrate (TMX) restored the ATP-induced increase
in intracellular Ca2+ despite the presence of 17ß-estra-
diol, thus increasing airway surface liquid production.
TMX was more potent than the pure ER antagonist
ICI182780. However, direct measurements of the ef-
fects of TMX on CaCC currents are not available.
The aim of this study was to determine the effects of
17β-estradiol and TMX on CaCC currents in human
bronchial epithelial cells carrying the ΔPhe508-CFTR
mutation both in homozygosis and in heterozygosis. The
increase of chloride membrane current promoted by the
application of TMX could be an additional support to in-
duce transepithelial water flux. Ultimately, the goal was to
investigate the potential role of TMX as a co-adjuvant to
existing pharmacological therapies for CF.
Methods
Cell cultures
Electrophysiological measurements were performed
on single cells of the immortalized cell lines CFBE and
IB3–1, created from primary cultures of human bron-
chial epithelial cells carrying the F508del/F508del [15]
and F508del/W1282X [16] mutation, respectively.
Cells were maintained in an incubator at 37 °C in 5%
CO2, and seeded in 35 mm Petri dishes the day before
the experiment. We also used 16HBE epithelial cells
as a control in the experiment whose results are
shown in Fig. 1.
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Electrophysiology
Perforated patch clamp experiments were performed ac-
cording to a standard technique. Gramicidin (10 or 20 μM)
was added to the electrode solution to reach the whole cell
configuration. The temperature at the recording site was
monitored and its average value, determined from ten dif-
ferent measurements on different days, was 28 °C ± 2 °C.
Cells were bathed with a solution composed of 150 mM
NMDG-Cl, 1 mM MgCl2, 2 mM CaCl2, 10mMHEPES,
10 mM glucose, and 30 mM mannitol or raffinose, pH 7.4.
The extracellular solution was kept hypertonic (337 mOsm)
in order to inhibit currents generated by cell swelling. The
different compounds tested in this study were added to the
external solution at the concentration and at the time of in-
cubation reported on each plot. The pH of the external so-
lution was tested after addition of every molecule used in
our experiments. A fast perfusion system was used to
deliver the different compounds acutely or to ensure that
the cells were constantly in the presence of the drug used
in the incubation phase. The patch electrode was pulled
with a Sutter P97 horizontal puller to a tip diameter of 1–
2 μm and a resistance of 5–7 MΩ and filled with 145 mM
KCl, 1 mM MgCl2, 0.5 mM CaCl2, and 10 mM HEPES,
pH 7.25 to which gramicidin was added just before the ex-
periment. The electrical stimulation protocol consisted of
square voltages from − 80 to + 80 mV, with 20 mV steps
and a duration of 800 msec. Cell medium was discarded
from the Petri dish and replaced with the extracellular solu-
tion at the beginning of the experiment. Continuous extra-
cellular solution was perfused by means of an automated
perfusion system (RSC-200, Bio-Logic Science Instru-
ments, FR). After getting complete electrical access to the
cell, currents were recorded every minute up to register at
least three stable traces. Different test solutions were
Fig. 1 Total membrane current of 16HBE and CFBE epithelial cells elicited by ±80 mV voltage in 20 mV steps. Holding potential − 40 mV. a whole
cell current recordings from single 16HBE cells in the control condition (top), after stimulation with 10 μM forskolin (middle) and after perfusion
with the CFTR ion channel inhibitor Inh-172 (bottom). b whole cell current recordings from CFBE single cells in the control condition (top), after
stimulation with 10 μM forskolin (bottom). c current/voltage relationships of 16HBE total membrane currents in the control condition (squares),
after addition of 10 μM forskolin (circles; n = 6) and in the presence of Inh-172 (triangles; n = 3). d current/voltage relationships of CFBE total
membrane currents in the control condition (squares n = 5) and after addition of 10 μM forskolin (circles; n = 7)
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perfused accordingly with the same protocol. Solution
change around the cell under observation occurred in less
than a second.
3,17β-dihydroxy-1,3,5(10)-estratriene(17β-estradiol),
(Z)-1-(p-dimethylaminoethoxyphenyl)-1,2-diphenyl-1-
butene(tamoxifen citrate, TMX), 7β-acetoxy-8,13-epoxy-1α
,6β,9α-trihydroxylabd-14-en-11-one (forskolin, FSK), 3-[(3-
trifluoromethyl)phenyl]-5-[(4-c'arboxyphenyl)methylene]-2-
thioxo-4-thiazolidinone (Inh-172) and 5-nitro-2-(3-phenyl-
propylamino)benzoic acid (NPPB) were purchased from
SIGMA, Italy [17]. Ivacaftor (VX-770) and lumacaftor (VX-
809) (Selleckchem) were purchased from Absourche Diag-
nostics GmbH, Munchen, Germany. Ivacaftor (VX-770) and
lumacaftor (VX-809), recently licensed for the treatment of
some CFTR mutations, are able to increase CFTR protein in
the cell membrane and to enhance chloride flux [18]. In our
study we tested the effects of the association ivacaftor/luma-
caftor on chloride currents to compare quantitatively the ef-
fects of TMX on chloride currents, and to evaluate, in our
setting, a possible synergism between the association Ivacaf-
tor/lumacaftor and TMX.
We considered only experiments with a membrane re-
sistance between 1 and 1.2 GΩ and an access resistance
of 40–60 MΩ to ensure a correct current recording.
Current amplitude was calculated as an average of three
consecutive single current traces at the same test voltage
considering only the last 100 msec. Currents are
expressed in current/voltage plots as absolute current
value (Fig. 1) or as a density using the cell capacitance as
a measure of cell surface. We used an Axopatch 200B
Fig. 2 Effect of 17β-estradiol, ATP and tamoxifen (TMX) on CFBE single cell membrane current density. a current/voltage relationship of control
cells (squares; n = 15) and in the presence of the chloride channel blocker NPPB 300 μM (triangles; n = 4). b current density versus membrane
voltages in control cells (squares; n = 15) in the presence of 10 nM 17β-estradiol (triangles; n = 5) or 100 μM ATP (circles; n = 6). ATP (100 μM) was
not able to increase current density once in combination with 10 nM 17β-estradiol (diamonds; n = 6). c current/voltage relationship of control
cells (squares; n = 15), after perfusion with 10 μM TMX (circles; n = 7). The addition of 100 μM ATP induced a marked increase of current density
(triangles; n = 6). d and e current density box chart plots at + 80 mV membrane voltage related to the experiments reported in B and C
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for current recording and Pclamp9 to collect the experi-
mental current traces. Clampfit 9 was used for analysis
of the currents. ORIGIN 9 was used to process the data
and an unpaired t-test was applied to calculate the sig-
nificance of results, with values of p < 0.05 considered
statistically significant. Quantitative data were collected
from experiments performed in triplicate or quadrupli-
cate and expressed as mean ± s.e.m., except for time-
lapse experiments (mean ± s.d.). Current density/voltage
relationships were analyzed as following: for each condi-
tion, we plotted every experiment (the number of trials
is reported in the figure legends) and extrapolated the
linear regression for the curve (all statistically significant,
with R2 ≥ 0.9). For analyses of two conditions, we used a
two-sample t-test; otherwise we performed a two-way
ANOVA on the slopes of every experimental group. In
the box chart plots, the solid lines within the boxes rep-
resent the median values. The square within the boxes is
the average, and the boxes show the 25th and 75th per-
centile range of the measured elements. The maximum
and minimum values are depicted as horizontal bars,
and the symbols to the right of the box represent the
numbers of trials.
Results
Our experiments were based on the hypothesis that
stimulation of CaCC currents could restore the perme-
ability to chloride ions that is downregulated by the
Fig. 3 Effect of 17β-estradiol, ATP and tamoxifen on IB3–1 single cell membrane current density. a current/voltage relationship of control cells
(squares; n = 12) and cells in the presence of 300 μM NPPB, a chloride channel blocker (triangles; n = 6). b current density versus membrane
voltages in control cells (squares; n = 12), in the presence of 10 nM 17β-estradiol (triangles; n = 5) or in the presence of 100 μM ATP (circles;
n = 4). ATP was not able to increase current density once in combination with 10 nM 17β-estradiol (diamonds; n = 5). c current/voltage
relationship of control cells (squares; n = 12), after perfusion with 10 μM TMX (circles; n = 6) in the presence of 10 nM 17β-estradiol. The addition
of 100 μM ATP induced a marked increase in current density (triangles; n = 5). d and e current density box chart plots at + 80 mV membrane
voltage related to the experiments reported in B and C
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malfunctioning of the CFTR ion channel. Homozygosity
for the 508 mutation in CFBE cells reduces the chloride
flux through the plasma membrane almost to zero,
thereby preventing the movement of water. Comparing
control 16HBE epithelial cells with the CFBE clone (see
methods), the absence of the cAMP-activated chloride
permeability in the cells carrying the F508−/− point mu-
tation is evident. Perforated patch current recordings ob-
tained in both types of cells are shown in Fig. 1. The
effect of perfusion of 10 μM FSK, causing a cytoplasmic
increase of cAMP, is evident in 16HBE but not in CFBE
cells. In addition, the increase of membrane current in
16HBE cells was totally inhibited by 10 μM Inh-172, a
specific CFTR channel blocker. The experiment on
CFBE cells, whose results are shown in Fig. 1, demon-
strates the absence of CFTR channel activity in the mu-
tated clone [17].
Perforated patch experiments performed on CFBE cells
in control conditions showed a current inversion at − 47.8
± 6.5 mV, consistent with limited chloride permeability.
The basic current of CFBE cells was inhibited by 300 μM
NPPB (Fig. 2a). To assess the inhibitory action of the es-
trogen hormone, CFBE cells were exposed to 10 nM
17β-estradiol for 30 min. The presence of 17β-estradiol
significantly reduced the chloride currents, both in basal
conditions and in the presence of ATP (100 μM). Activa-
tion of the purinergic receptor P2Y2 has the effect of
CaCC agonism (Fig. 2b and d). However, stimulation with
10 μM TMX induces an increase of intracellular calcium
[10]. Accordingly, TMX completely restored the currents
abolished by 17β-estradiol, both in basal conditions and
after stimulation with ATP (Fig. 2c and e).
The same experimental paradigm was applied to single
IB3–1 cells: the findings are illustrated in Fig. 3. Cells with
508 mutation in heterozygosis showed a current reversal
potential of − 57.8 ± 7.1 mV, consistent with greater per-
meability to chloride than that of CFBE cells. Figure 3a
shows the effect of 300 μM NPPB on the basic membrane
current of IB3–1 cells. IB3–1 cells show a similar behavior
to that of CFBE cells after stimulation with 17β-estradiol
and ATP (Fig. 3b and d) and in the presence of TMX and
ATP simultaneously with estrogen stimulation.
Collectively, these findings indicate that the basic
membrane currents recorded in CFBE and IB3–1 cells is
mainly carried by chloride through the CaCC.
TMX had a direct effect on membrane ionic perme-
ability of CFBE and IB3–1 cells. Figure 4 shows the re-
sults of parallel studies of CFBE and IB3–1 cells
stimulated by TMX in perforated patch experiments.
Figure 4a and b depict current/voltage relationships for
Fig. 4 Effect of TMX on current density of single CFBE and IB3–1 epithelial cells. a example of current/voltage relationship of CFBE cells in control
conditions (squares) and in the presence of 10 μM TMX (circles). b example of current/voltage relationship of IB3–1 cells in control conditions
(squares) and in the presence of 10 μM TMX (circles). c box chart plot of the membrane current density at + 80 mV for CFBE cells in the control
condition (n = 18) and in the presence of TMX (n = 9). The right part of the plot shows average current density for IB3–1 cells in control
conditions (n = 12) and after exposure to TMX (n = 6)
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CFBE and IB3–1 cells, respectively, in control conditions
and after stimulation with 10 μM TMX.
The membrane current stimulation produced by TMX
(Fig. 5a, circles) can be further enhanced by the addition
of 100 μM ATP (Fig. 5a, triangles). Acute application of
NPPB totally inhibits the whole cell current stimulated
by TMX and ATP (Fig. 5b), confirming that the final tar-
gets of TMX and ATP are CaCC.
The in vitro efficacy of TMX on membrane chloride ionic
currents in CFBE cells was compared with that of two re-
cently discovered CFTR permeability enhancers. Ivacaftor
(VX-770) and lumacaftor (VX-809) are two approved drugs
(Orkambi®, Vertex Pharmaceuticals) used in combination
for the treatment of CF in patients with F508-del mutation
in homozygosis. Using an Ussing chamber, Van Goor and
colleagues showed that the two drugs increased the CFTR
current in experiments performed on a cell monolayer. The
procedure enabled the transepithelial current to be re-
corded in the voltage-clamp mode [18]. In our experiments,
we monitored the change of chloride current density on
single CFBE cells incubated for 24 h with 3 μM VX-809.
Figure 6a shows a current/voltage plot on CFBE cells
treated with VX-809 and acutely stimulated with 1 μM
VX-770 immediately prior to electrophysiological measure-
ments. At the end of each experiment we also added
10 μM FSK to the external solution. Membrane current
amplitude was enhanced upon VX-809/VX-770 exposure;
the subsequent application of FSK resulted in a trend to-
wards an increase, although this was not statistically signifi-
cant. The CFTR blocking agent Inh-172 completely
inhibited the membrane current (Fig. 6a and b).
To compare the effects of TMX/ATP with those of
VX-809/VX-770/FSK, average current/voltage relation-
ships for both the experimental conditions were plotted
(Fig. 7a) and compared with the membrane current in
basal conditions. Both curves show a significant increase
of the current density. At the 80 mV voltage step, TMX/
ATP caused a mean increase in membrane permeability of
29% compared to that produced by VX-809/VX-770/FSK.
The combined effects of TMX/ATP and VX-809/
VX-770/FSK were seen to be additive. CFBE cells were
Fig. 5 Effect of TMX and ATP on current density in CFBE cells. a
example of current/voltage relationship of cells in control conditions
(squares), in the presence of 10 μM TMX (circles) and after addition
of 100 μM ATP (triangles). b example of current/voltage relationship
of cells in control conditions (squares), and in the presence of 10 μM
TMX + 100 μM ATP (circles). Membrane current stimulated by TMX +
ATP was almost totally inhibited by 300 μM NPPB (triangles). c plot
of membrane current density expressed as a percentage of increase
at + 80 mV relative to the value of the current in control conditions
(n = 15; p≥ 0.001). TMX in combination with ATP (n = 10) produced
a significant increment compared with TMX stimulation alone (n =
11; p ≥ 0.05). Addition of NPPB completely inhibited the
current (n = 6)
Imberti et al. Respiratory Research  (2018) 19:198 Page 7 of 11
exposed to VXs/FSK and, after a steady current had
been reached, to TMX/ATP. The current/voltage rela-
tionship shown in Fig. 8a depicts the membrane current
elicited at the different voltages in the presence of VXs/
FSK (squares), followed by addition of TMX/ATP (cir-
cles) and, finally, perfusion with CFTR and CaCC
blockers (triangles). The histogram in Fig. 8b illustrates
the different current density values at a membrane volt-
age of + 80 mV. The average TMX/ATP current value
has been imported from Fig. 7. The light gray column
on the right of Fig. 8b presents the plain sums of VXs/
FSK plus TMX/ATP single averages.
Discussion
Our study shows that TMX increases the CaCC cur-
rents by two mechanisms: 1) indirectly, as an antagon-
ist of the negative effect of 17β-estradiol on currents,
and 2) directly, independently from the antiestrogen ef-
fect, acting on the CaCC, the alternate chloride trans-
port pathway (Fig. 9) The effect of TMX on CaCC
develops soon after TMX treatment. The
CaCC-dependent currents elicited by TMX are
Fig. 6 Effect of ivacaftor (VX-770) and lumacaftor (VX-809) on current
density of CFBE cells. a example of current/voltage relationship of cells
in control conditions (squares), in the presence of 1 μM VX-770 and
3 μM VX-809 (circles) and after addition of 10 μM forskolin (triangles).
Addition of the CFTR ion channel blocker Inh-172 reduced the
transmembrane current almost to that occurring in control conditions
(diamonds). b chart plot of membrane current density at + 80 mV
relative to the value of the current in control conditions (n = 11),
stimulated by VX-770 and VX-809 (n= 8) and after the addition of
forskolin (n = 8) compared to current inhibitor Inh-172 (n= 4; p≥ 0.001)
Fig. 7 Comparison of the effect of VX-770/VX-809/FSK and TMX/ATP
on CFBE cell current density. A: example of current/voltage
relationships of cells in control conditions (squares), in the presence
of VXs/FSK triangles) and in those treated with TMX/ATP (circles). B:
The combination of TMX + ATP (n = 8) showed greater efficiency
than VXs/FSK at increasing chloride membrane currents (n = 7; p <
0.001). Both treatments elicited highly significant increases in current
density compared to the density in control conditions (n = 12)
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quantitatively superior to the CFTR-dependent chlor-
ide currents elicited by ivacaftor+lumacaftor. Of note,
the combined administration of TMX/ATP and VXs/
FSK had an additional effect on chloride currents.
CFTR ion channels in healthy subjects ensure the cor-
rect hydration of the respiratory system airway surface.
CFTR chloride flux induces an osmotic driven move-
ment of water through the apical membrane of respira-
tory epithelia. Water release in the lumen dilutes the
mucopolysaccharide layer on the luminal cell surface.
Fluidity of mucus towards the external environment en-
sures correct removal of solid residues introduced dur-
ing breathing [4]. Inflammation and host-defense defect
also contribute to the pathophysiology of CF lung dis-
ease and lung function deterioration [4].
In CF, CaCC in airway epithelial cells contribute to the
secretion of chloride and water. Although the role of
CaCC in normal and CF airway epithelial cells has not
been completely elucidated, several lines of evidence
suggest that CaCC could have clinically relevant effects
in CF patients. Mice homozygous for disruption of the
CFTR genes, unlike their human counterparts, fail to
show any gross lung pathology [19]. It is possible that
CaCC are more expressed in mice, thus compensating
for the lack of CFTR function. By contrast, mice knock-
out for the TMEM16A gene, the gene encoding a CaCC
in different secretory epithelia [20–22], exhibit pheno-
typic abnormalities consistent with a role in fluid and
electrolyte homeostasis [23–25]. Finally, in their pivotal
study, Knowles and colleagues [26] showed that admin-
istration of the CaCC activating agents ATP and UTP in
vivo and in vitro was more effective at inducing changes
in nasal potential difference in CF patients than in nor-
mal controls, suggesting that the activity of CaCC is
more pronounced in CF cells than in non-CF cells.
Coakley et al. [10] demonstrated in CF airway epithe-
lial cells that the acute addition of 17ß-estradiol reduced
the ATP-induced increase in intracellular Ca2+and the
production of airway surface liquid. The presence of
TMX restored the intracellular Ca2+ concentration and
potentiated the ATP-induced airway surface liquid secre-
tion, even in the presence of 17ß-estradiol. Our study
confirms the results obtained by Coakley et al. [10] and
gives new insights on the action of TMX. We explored
the possibility of increasing chloride ion fluxes in single
epithelial cell cultures, CFBE cells carrying the 508 mu-
tation in homozygosis and IB3–1 cells with the same
mutation but in heterozygosis, by stimulating the CaCC.
Stimulation of CaCC could be an effective way of creat-
ing additional chloride flux in order to promote the
movement of water. We found that TMX acts both in-
directly, as an antagonist of the negative effect of
17β-estradiol on chloride efflux, and directly, independ-
ently of its antiestrogen effect, acting on the CaCC, the
alternate chloride transport pathway [17].
TMX, counteracting the effect of 17β-estradiol and
acting on the P2Y purinergic receptor, restores the
intracellular Ca2+ concentration [10]. It is likely that
Fig. 8 Synergic action of VXs/FSK and TMX/ATP on increasing
membrane chloride current in CFBE cells. a example of the current/
voltage relationship showing current density data from CBE cells
after incubation with VXs/FSK (squares) and subsequent addition of
TMX/ATP (circles) compared with control condition (triangles). b the
histogram with the single experiments (grey diamonds) compares
current density at + 80 mV membrane potential for CFBE cells
stimulated with VXs/FSK (n = 4), TMX/ATP (n = 7) or the combination
of both compounds (n = 4). The ion channel blockers Inh-172 and
NPPB drastically reduced the membrane current (n = 3). The values
of the light gray column on the right of the histogram were
obtained by mathematical addition of the average current densities
of cells stimulated separately with VXs/FSK and TMX/ATP
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the increase of intracellular Ca2+was responsible for
the increment of chloride currents observed in our
study, which was further amplified by the presence of
ATP, a P2Y2 activator (Figs. 2, 3, 4, and 5). The whole
cell increase of chloride current density was relevant
and greater than that elicited by the association of
VX-809 + VX-770 plus FSK (Fig. 7). The direct effect
of TMX was evident after a few seconds, suggesting
that TMX, rather than its metabolites, is responsible
for the activation of CaCC. Combined experiments
using both VXs/FSK and TMX/ATP (Fig. 8) demon-
strated an additional effect on membrane current.
This is very important in the prospective of a com-
bined therapeutic use of both treatments. However,
the combined action of VXs/FSK and TMX/ATP pro-
duced a smaller increment of the membrane perme-
ability than expected from the mathematical addition
of the average single current increases due to each
compound. There are several possible explanations for
this. For example, intracellular calcium mobilization
could act on different regulatory pathways. As a con-
sequence, activation of chloride flux by one com-
pound could be responsible for partial activation of
other pathways.
To demonstrate that TMX by acting on CaCCs by-
passes the CFTR defect, in our study we used two cell
lines, CFBE cells, bearing the most frequent mutation
F508−/− (class II mutation, defective processing), and
IB3–1 cells, bearing the less frequent mutation F508
del/W1282X (class I mutation, premature stop codon).
We used concentrations of TMX which can be attained
in human airways in order to extrapolate our results to
the clinical setting. Our findings confirm that TMX by-
passes the CFTR defect and, therefore, it might be a
curative, mutation-independent treatment applicable to
all patients with CF. Adult premenopausal women with
CF might gain further advantage from treatment with
TMX during the ovulatory period (approximately
1 week per month), when estrogens inhibit CaCC cur-
rents [10].
A limit of our study was that it was performed in
single cells, rather than in airway epithelial tissue. The
effects of TMX on mucociliary transport and inflamma-
tion should be studied also in CF animal models.
However, “in vitro” cell-based models, which are cost-ef-
fective and give preliminary reliable information, have
been of immense value for the process of developing
new strategies in CF.
Conclusion
CF is a monogenic disease with a great number of
genetic variants of CFTR. The effects of environmental
factors and modifier genes, which can influence the re-
sponse to therapeutic agents strongly suggest that the
treatment of CF might require different types of drugs in
combination. Treatment with TMX might be
Fig. 9 Schematic model of the possible mechanisms of action of tamoxifen. Tamoxifen could be active on different targets. It appears to
downregulate estrogen stimulation. On the other hand, tamoxifen interacts with P2Y2 purinergic receptors, releasing calcium from the internal
stores via IP3 stimulation. However, tamoxifen could upregulate the chloride membrane current by acting directly on CaCC
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complementary to and synergistic with other new thera-
peutic agents such as those acting on the CFTR defect
and trafficking, and/or those inhibiting epithelial sodium
channel activity. The convergent therapeutic effects of
such agents could be highly beneficial for CF patients.
Therapeutic interventions acting on channels alternative
to CFTR (e.g., ENaC inhibitors) and a study evaluating the
impact of sex hormones (estrogen and progesterone) on
lung disease are ongoing [27, 28].
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